77.17
전일 마감가:
$77.64
열려 있는:
$77.49
하루 거래량:
494.67K
Relative Volume:
0.31
시가총액:
$13.37B
수익:
$8.28B
순이익/손실:
$1.43B
주가수익비율:
9.4522
EPS:
8.1642
순현금흐름:
$-203.00M
1주 성능:
-5.54%
1개월 성능:
+4.30%
6개월 성능:
-2.21%
1년 성능:
+3.72%
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SOLV
Solventum Corp
|
77.21 | 13.45B | 8.28B | 1.43B | -203.00M | 8.1642 |
|
ISRG
Intuitive Surgical Inc
|
331.62 | 122.06B | 11.03B | 3.16B | 2.83B | 8.7254 |
|
BDX
Becton Dickinson Co
|
152.98 | 42.20B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.16 | 32.85B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.46 | 31.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
190.98 | 27.98B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-24 | 개시 | Rothschild & Co Redburn | Sell |
| 2026-01-26 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-12-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-09-11 | 개시 | Jefferies | Hold |
| 2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Argus | Hold → Buy |
| 2025-06-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
SOLN5759822 Bond Profile — Key Metrics - TradingView
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
SOLN5957968 Bond Profile — Key Metrics - TradingView
Solventum’s Q2 2026 Earnings: What to Expect - Inkl
Solventum Reports Fourth Quarter 2024 Financial Results and Intr - GuruFocus
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
SOLN5759602 Bond Profile — Key Metrics - TradingView
Frontier tech research, news & data - MLQ.ai
SOLN5759824 Bond Profile — Key Metrics - TradingView
SOLN5759603 Bond Profile — Key Metrics - TradingView
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
SOLN5957404 Bond Profile — Key Metrics - TradingView
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026 - BioSpace
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum to report Q2 FY26 earnings on August 5, 2026 - scanx.trade
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
SOLN5957967 Bond Profile — Key Metrics - TradingView
SOLN5759820 Bond Profile — Key Metrics - TradingView
BTIG Adjusts Solventum Price Target to $91 From $89, Maintains Buy Rating - marketscreener.com
Solventum Corporation (SOLV) Stock Analysis: Evaluating a 7% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews
Solving A Lackluster Growth Outlook Should Be Solventum’s Next Priority (NYSE:SOLV) - Seeking Alpha
The Bull Case For Solventum (SOLV) Could Change Following Dual Russell 2500 Index Inclusion - simplywall.st
Solventum Foundation and America’s ToothFairy Join Forces - Dentistry Today
Solventum Corporation (SOLV) Stock Analysis: Exploring a 4.96% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Solventum (SOLV) Joins Russell Indices, Is Its 6% Undervalued View Still Compelling? - simplywall.st
solventum-logo-horz-clr-rev-rgb - Dentistry UK
Solventum (SOLV) Is Up 6.4% After Russell 2500 Value Inclusion Shifted Its Healthcare Role - simplywall.st
Solventum stock: Is SOLV underperforming the healthcare sector? - MSN
Solventum Corporation(NYSE: SOLV) added to Russell 2500 Index - marketscreener.com
Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
3M updates health spinoff tax details, shares stay on investor radar - Ad-hoc-news.de
Price to sales forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum Corporation Actuals & Estimates (NYSE:SOLV) - TradingView
Enterprise value to revenue forward of Solventum Corporation – NYSE:SOLV - TradingView
SOLV Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum (SOLV) Short Interest & Short Float | Updated Jun 2026 $SOLV - MarketBeat
Solventum Stock Sinks as Investors Question Its Health - TipRanks
Why Is (NYSE:SOLV) Advancing Healthcare Growth in the S&P 500? - Kalkine Media
What Solventum (SOLV) Results Mean As Growth Plans Support Its Valuation - simplywall.st
Solventum (SOLV) Holds Steady Near Support as Resistance LoomsGrowth Stock Picks - Město Břeclav
Solventum Corp (SOLV) Institutional Confidence - TradingKey
Solventum Data Breach Affects Exposes PHI and PII of Patients - Claim Depot
Solventum Corporation (SOLV) Stock Report: Insights into a Healthcare Giant with 8.91% Potential Upside - DirectorsTalk Interviews
Solventum Stock: Is SOLV Underperforming the Healthcare Sector? - Barchart.com
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):